Adaptimmune Therapeutics Plc ADR (ADAP) Outlook Starting To Look Brighter?

Adaptimmune Therapeutics Plc ADR (ADAP) concluded trading on Wednesday at a closing price of $0.31, with 6.75 million shares of worth about $2.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -67.91% during that period and on April 03, 2025 the price saw […]

Growth Story Still Intact For Adaptimmune Therapeutics Plc ADR (ADAP)

Adaptimmune Therapeutics Plc ADR (ADAP) concluded trading on Thursday at a closing price of $0.28, with 13.94 million shares of worth about $3.9 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -73.33% during that period and on March 20, 2025 the price saw […]

Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) – Suitable For Long Term Buy?

Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.